- Lawdragon:
In Conversation with Tara Sutton, Head of The Mass Tort Practice at Robins Kaplan - December 2023Advancement Proceedings: A Litigation Expense Your Client Might Not Have Anticipated
- December 2023Who Pays When You Fight Over a Trust?
- December 2023Can the Threat of Fees Discourage Unnecessary Fiduciary Disputes? Maybe...
- December 13, 2023Acadia Pharms. Inc. v. Aurobindo Pharma Ltd.
- December 7, 2023H. Lundbeck A/S v. Lupin Ltd.
- Fall 2023All Is Not Lost: Personal Jurisdiction in a Post-BMS World
- A New Era of Copyright Litigation in Hollywood
- E-Commerce Platform Liability for Trademark Infringement
- November 8, 2023Generative Artificial Intelligence, LLMs, And Fair Use After Warhol: The Copyright Office and Accountability
- November 7, 2023Eisai R&D Mgmt. Co., Ltd. v. Dr Reddy’s Labs., Inc.
- November 6, 2023Actelion Pharms. Ltd. v. Mylan Pharms. Inc.
- November 1, 2023Norwich Pharms., Inc. v. Becerra
- Fourth QuarterANDA Litigation Settlements
- Bausch Health Ireland Ltd. v. Padagis Israel Pharms. Ltd.
- Recent Litigation Disputes Involving Generative AI
- 2023 Bulletin - Third QuarterGENERICally Speaking: A Hatch-Waxman Litigation Bulletin 2023 Q3
- Third QuarterANDA Approvals
- Third QuarterANDA Litigation Settlements
- Third QuarterGeneric Launches
- Third QuarterNew ANDA Cases
- October 9, 2023Q&A: The Crossroads Where Generative AI Meets Copyright Law
- Fourth QuarterGeneric Launches
- Fourth QuarterNew ANDA Cases
- Fourth QuarterANDA Approvals
- Novartis Pharms. Corp. v. Alembic Pharms. Ltd.
- CMP Development, LLC v. Amneal Pharms. LLC
- Allergan USA, Inc. v. MSN Labs. Private Ltd.
- Takeda Pharms. U.S.A., Inc. v. Mylan Pharms., Inc.
- September 2023Walking the Razor’s Edge: Client Capacity and the Attorney-Client Relationship
- September 2023Meet Our Keynote Speaker: Journalist and New York Times Contributor Katie Engelhart
- September 2023Evenstad Family Trial Aftermath: Rule 408 May Not Be Used as a Sword and Shield
- September 8, 2023Zogenix, Inc. v. Apotex Inc.
- September 8, 2023Purdue Pharma L.P. v. Accord Healthcare Inc.
- Colorado Expands Antitrust Protection
- July 18, 2023Copyright: Rights Even Heroes Can't Protect
- UCB, Inc. v. Annora Pharma Priv. Ltd.
- Taiho Pharm. Co., Ltd. v. Eugia Pharma Specialties Ltd.
- August 2023Minnesota Passes Survivorship Bill, Expanding Justice for Victims of Medical Malpractice and Wrongful Death
- August 2023Minnesota Bans Non-Competes Formed on or After July 1, 2023: Assessing Remaining Strategies to Protect Confidential Information and Trade Secrets
- August 7, 2023Pointers For Tackling Antitrust Class Action Set-Aside Orders
- Second QuarterGenerically Speaking: A Hatch-Waxman Litigation Bulletin
- Mallory Gives Plaintiffs a Better Shot at Justice
- United Therapeutics Corp. v. Liquidia Technologies, Inc.
- Second QuarterANDA Approvals
- Second QuarterANDA Litigation Settlements
- Second QuarterGeneric Launches
- Second QuarterNew ANDA Cases
- Orexo AB v. Sun Pharm. Indus. Ltd.
- July 7, 2023PTAB Overruled: A New Analysis For Real Party In Interest
